Latest Breaking News On - Christophe hotermans - Page 1 : comparemela.com

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChristophe hotermansSarah waltersWaddington cruzWorld analysis utilizing electronic health recordsElectronic health records database analysisInternational symposium on amyloidosisElectronic health recordsIonis pharmaceuticalsHead of global medical affairsDrug administrationAstrazeneca pharmaceuticalsColumbia university irving medical centerAstrazeneca rare diseaseInternational symposium

AstraZeneca: presents new clinical data at AAN -April 08, 2024 at 05:59 am EDT

Alexion and AstraZeneca will present new clinical and real-world data from its leading rare neurology portfolio at the American Academy of Neurology annual meeting in Denver from April 13-18, 2024..

United statesChristophe hotermansAmerican academy of neurologyHead of global medical affairs at alexionAmerican academySenior vice presidentGlobal medical affairs

Alexion Reveals C5 Inhibition Impact on NMOSD at MSMilan2023

Alexion Reveals C5 Inhibition Impact on NMOSD at MSMilan2023
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChristophe hotermansHead of global medical affairsResearch in multiple sclerosisOdense university hospitalAlexion pharmaceuticals incAmericas committee for treatmentMeeting of the european committee for treatmentAstrazeneca rare diseaseJoint meetingEuropean committeeMultiple sclerosisAmericas committeeSenior vice presidentGlobal medical affairs

AstraZeneca : Alexion data at 9th Joint ECTRIMS-ACTRIMS Meeting (MSMilan2023) showcase impact of C5 inhibition in NMOSD -October 11, 2023 at 02:21 am EDT

Alexion, AstraZeneca Rare Disease, will present new data at MSMilan2023, the 9th Joint Meeting of the European Committee for Treatment and Research in Multiple Sclerosis and Americas Committee.

United statesUnited kingdomChristophe hotermansOdense university hospitalResearch in multiple sclerosisHead of global medical affairsAlexion pharmaceuticals incMeeting of the european committee for treatmentAmericas committee for treatmentAstrazeneca rare diseaseJoint meetingEuropean committeeMultiple sclerosisAmericas committeeSenior vice presidentGlobal medical affairs

AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases

AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Christophe hotermansAnas younesGlobal medical affairsEuropean hematology association annual meetingEuropean hematology associationAnnual meetingRare diseaseSenior vice president